SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4,567 Cr | ₹4,061 Cr | ₹3,647 Cr | ₹4,639 Cr | ₹4,909 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4,567 Cr |
Mar2023 | ₹4,061 Cr |
Mar2022 | ₹3,647 Cr |
Mar2021 | ₹4,639 Cr |
Mar2020 | ₹4,909 Cr |
How is Contingent Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4,567 Cr | 12.46 | |
Mar2023 | ₹4,061 Cr | 11.36 | |
Mar2022 | ₹3,647 Cr | -21.38 | |
Mar2021 | ₹4,639 Cr | -5.51 | |
Mar2020 | ₹4,909 Cr | - |
Compare Contingent Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹405,169.8 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.3% |
-2.9% |
11.5% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses